{"disease":{"id":"her2-positive-malignancies","name":"her2 positive malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04684459","title":"Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Sichuan University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}